|

Diabetes Clinical Trials in Michigan

61 recruiting studies across 19 cities

All Trials in Michigan

Phase
Trial Phase Location
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2Ann Arbor
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPhase 3Ann Arbor
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional CohortPhase 1Ann Arbor
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/2Ann Arbor
DFC 004 Biomarkers for Active Diabetic Foot Ulcers—Ann Arbor
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumEarly 1Ann Arbor
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)N/AAnn Arbor
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)N/AAnn Arbor
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)N/AAnn Arbor
Leveraging Interventions for Needs and Knowledge in DiabetesN/AAnn Arbor
Mechanism of SGLT2 Inhibition in the KidneyPhase 4Ann Arbor
Mechanisms of Fatigability With DiabetesN/AAnn Arbor
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 4Ann Arbor
Rare and Atypical Diabetes Network—Ann Arbor
Registry for Stage 2 Type 1 Diabetes—Ann Arbor
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney DiseasePhase 2Ann Arbor
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes—Ann Arbor
The RESET System Pivotal Clinical Trial (Protocol Revision K)N/AAnn Arbor
Transformative Research in Diabetic Nephropathy—Ann Arbor
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents—Ann Arbor
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPhase 3Bay City
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3Buckley
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarPhase 3Buckley
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to CagrisemaPhase 3Buckley
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.—Clinton Township
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of CareN/AClinton Township
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventPhase 2Dearborn
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3Dearborn
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/ADetroit
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Detroit
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 SystemN/ADetroit
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 DiabetesN/ADetroit
Family Intervention for Black Teens With Type 1 DiabetesN/ADetroit
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes—Detroit
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 DiabetesPhase 1/2Detroit
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With DiabetesN/ADetroit
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study—Detroit
Study of Enhanced Programming Stimulation with the Enterra® Therapy SystemN/ADetroit
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightPhase 3Farmington Hills
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseasePhase 2Flint
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2Flint
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityPhase 3Flint
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerPhase 1/2Grand Rapids
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Kalamazoo
Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without DiabetesN/AKalamazoo
Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialN/ALansing
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPhase 2Pontiac
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinPhase 3Saint Joseph
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusPhase 3Southfield
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 DiabetesPhase 3Southfield
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 3Southfield
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesPhase 3Southfield
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusPhase 3Southfield
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or OverweightPhase 2Southfield
SPYRAL GEMINI Pilot StudyN/ASouthfield
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusPhase 3Troy
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 3Troy
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusPhase 3Troy
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 DiabetesPhase 2Troy
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 2Troy
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 3Ypsilanti

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.